Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1994 Dec;220(6):768–774. doi: 10.1097/00000658-199412000-00010

Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma.

X Wang 1, R Heller 1, N VanVoorhis 1, C W Cruse 1, F Glass 1, N Fenske 1, C Berman 1, J Leo-Messina 1, D Rappaport 1, K Wells 1, et al.
PMCID: PMC1234479  PMID: 7986144

Abstract

BACKGROUND. The presence or absence of lymph node metastases in patients with malignant melanoma is the most powerful prognostic factor for predicting survival. If regional nodal metastases are found, the 5-year survival for the patient decreases approximately 50%. If the presence or absence of regional nodal metastases will determine which patients receive formal dissections or which patients enter adjuvant trials, then a technique is needed to accurately screen lymph node samples for occult disease. Routine histopathologic examination routinely underestimates the number of patients with metastases. This study was initiated to develop a highly sensitive clinically applicable method to detect micrometastases by examining lymph nodes for the presence of tyrosinase messenger RNA (mRNA). The hypothesis was that if mRNA for tyrosinase is found in the lymph node preparation, that finding is good evidence that metastatic melanoma cells are present. METHODS. The assay is accomplished using the combination of reverse transcription and double-round polymerase chain reaction (RT-PCR). The amplified samples are examined on a 2% agarose gel and tyrosinase cDNA is seen as a 207 base pair fragment. Lymph node preparations from 29 patients who were clinically stage I and II and undergoing elective node dissections were analyzed both by standard pathologic staining and RT-PCR. RESULTS. Eleven of 29 lymph node (38%) samples from 29 patients with intermediate thickness melanoma were pathologically positive. Nineteen of the 29 lymph node preparations (66%) were RT-PCR-positive, and these included all of the pathologically positive samples, so that the false-negative rate was 0. In a spiking experiment, one SK-Mel-28 melanoma cell in a background of one million normal lymphocytes could be detected, thus indicating the sensitivity of this method. In addition, analysis by restriction enzyme mapping showed that the amplified 207-bp PCR product produced is part of the tyrosinase gene sequence. CONCLUSION. The RT-PCR method is an extremely sensitive, reproducible, and efficient technique for the identification of micrometastases in patients with melanoma and could be widely applicable. If clinical correlation is obtained, staging of the melanoma patient becomes more accurate, and treatment becomes more standardized and rational, because all those patients who have evidence of nodal disease can be identified so that they may benefit from more extensive surgery (formal node dissections) or adjuvant therapies. Based on these results, RT-PCR could be a powerful tool to detect micrometastatic melanoma.

Full text

PDF
768

Images in this article

771Figure 1.
on p.771
772Figure 2.
on p.772
772Figure 3.
on p.772
772Figure 4.
on p.772
773Figure 5.
on p.773

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cho K. H., Hashimoto K., Taniguchi Y., Pietruk T., Zarbo R. J., An T. Immunohistochemical study of melanocytic nevus and malignant melanoma with monoclonal antibodies against S-100 subunits. Cancer. 1990 Aug 15;66(4):765–771. doi: 10.1002/1097-0142(19900815)66:4<765::aid-cncr2820660428>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  2. Cochran A. J., Wen D. R., Herschman H. R. Occult melanoma in lymph nodes detected by antiserum to S-100 protein. Int J Cancer. 1984 Aug 15;34(2):159–163. doi: 10.1002/ijc.2910340204. [DOI] [PubMed] [Google Scholar]
  3. Cochran A. J., Wen D. R., Morton D. L. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. An immunohistological study. Am J Surg Pathol. 1988 Aug;12(8):612–618. doi: 10.1097/00000478-198808000-00002. [DOI] [PubMed] [Google Scholar]
  4. Drepper H., Biess B., Hofherr B., Hundeiker M., Lippold A., Otto F., Padberg G., Peters A., Wiebelt H. The prognosis of patients with stage III melanoma. Prospective long-term study of 286 patients of the Fachklinik Hornheide. Cancer. 1993 Feb 15;71(4):1239–1246. doi: 10.1002/1097-0142(19930215)71:4<1239::aid-cncr2820710412>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  5. Feinstein A. R., Sosin D. M., Wells C. K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985 Jun 20;312(25):1604–1608. doi: 10.1056/NEJM198506203122504. [DOI] [PubMed] [Google Scholar]
  6. Fisher E. R., Swamidoss S., Lee C. H., Rockette H., Redmond C., Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer. 1978 Oct;42(4):2025–2031. doi: 10.1002/1097-0142(197810)42:4<2025::aid-cncr2820420452>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  7. Heller R., Becker J., Wasselle J., Baekey P., Cruse W., Wells K., Cox C., King B., Reintgen D. S. Detection of submicroscopic lymph node metastases in patients with melanoma. Arch Surg. 1991 Dec;126(12):1455–1460. doi: 10.1001/archsurg.1991.01410360025005. [DOI] [PubMed] [Google Scholar]
  8. Kwon B. S., Haq A. K., Pomerantz S. H., Halaban R. Isolation and sequence of a cDNA clone for human tyrosinase that maps at the mouse c-albino locus. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7473–7477. doi: 10.1073/pnas.84.21.7473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Morton D. L., Wen D. R., Wong J. H., Economou J. S., Cagle L. A., Storm F. K., Foshag L. J., Cochran A. J. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992 Apr;127(4):392–399. doi: 10.1001/archsurg.1992.01420040034005. [DOI] [PubMed] [Google Scholar]
  10. Norman J., Cruse C. W., Espinosa C., Cox C., Berman C., Clark R., Saba H., Wells K., Reintgen D. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg. 1991 Nov;162(5):432–437. doi: 10.1016/0002-9610(91)90255-c. [DOI] [PubMed] [Google Scholar]
  11. Prota G. Recent advances in the chemistry of melanogenesis in mammals. J Invest Dermatol. 1980 Jul;75(1):122–127. doi: 10.1111/1523-1747.ep12521344. [DOI] [PubMed] [Google Scholar]
  12. Redding W. H., Coombes R. C., Monaghan P., Clink H. M., Imrie S. F., Dearnaley D. P., Ormerod M. G., Sloane J. P., Gazet J. C., Powles T. J. Detection of micrometastases in patients with primary breast cancer. Lancet. 1983 Dec 3;2(8362):1271–1274. doi: 10.1016/s0140-6736(83)91150-9. [DOI] [PubMed] [Google Scholar]
  13. Reintgen D. S., Cox E. B., McCarty K. S., Jr, Vollmer R. T., Seigler H. F. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann Surg. 1983 Sep;198(3):379–385. doi: 10.1097/00000658-198309000-00014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ryan L., Kramar A., Borden E. Prognostic factors in metastatic melanoma. Cancer. 1993 May 15;71(10):2995–3005. doi: 10.1002/1097-0142(19930515)71:10<2995::aid-cncr2820711018>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  15. Slominski A., Costantino R. Molecular mechanism of tyrosinase regulation by L-dopa in hamster melanoma cells. Life Sci. 1991;48(21):2075–2079. doi: 10.1016/0024-3205(91)90164-7. [DOI] [PubMed] [Google Scholar]
  16. Smith B., Selby P., Southgate J., Pittman K., Bradley C., Blair G. E. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet. 1991 Nov 16;338(8777):1227–1229. doi: 10.1016/0140-6736(91)92100-g. [DOI] [PubMed] [Google Scholar]
  17. Trojani M., de Mascarel I., Bonichon F., Coindre J. M., Delsol G. Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer. 1987 Mar;55(3):303–306. doi: 10.1038/bjc.1987.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wallack M. K., Bash J. A., Leftheriotis E., Seigler H., Bland K., Wanebo H., Balch C., Bartolucci A. A. Positive relationship of clinical and serologic responses to vaccinia melanoma oncolysate. Arch Surg. 1987 Dec;122(12):1460–1463. doi: 10.1001/archsurg.1987.01400240108020. [DOI] [PubMed] [Google Scholar]
  19. Walts A. E., Said J. W., Shintaku I. P. Cytodiagnosis of malignant melanoma. Immunoperoxidase staining with HMB-45 antibody as an aid to diagnosis. Am J Clin Pathol. 1988 Jul;90(1):77–80. doi: 10.1093/ajcp/90.1.77. [DOI] [PubMed] [Google Scholar]
  20. Wells C. A., Heryet A., Brochier J., Gatter K. C., Mason D. Y. The immunocytochemical detection of axillary micrometastases in breast cancer. Br J Cancer. 1984 Aug;50(2):193–197. doi: 10.1038/bjc.1984.162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. de Mascarel I., Trojani M., Abadjian G., Durand M., Bonichon F., Coindre J. M., Meuge-Moraw C. Ganglions axillaires dans les cancers du sein. Comparaison des techniques d'analyse histologique standard et en coupes macroscopiquement sériées. Bull Cancer. 1982;69(5):451–455. [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES